Benchmarking of Biopharmaceutical Outsourcing Practices

Note: The 2011 CRO Quality Benchmarking Report is Now Available

Q2, 2010

This is a substantial study based on interviews with 150 pharmaceutical and biotechnology company representatives. Respondents graded 25 small, mid-size and large CROs across 20 important capabilities that affect provider selection and delivery quality. The report contains 320 pages, including over 300 charts and graphs, and in-depth analysis not previously available to the industry.

This study - designed, executed and analyzed by research professionals from the drug development industry - is a "Consumer Reports"-style guide to buying and delivering quality product development services.

Report Contents:

This report contains the following five sections.

1. Industry Leaders: This section outlines which service providers are seen as industry leaders, which providers are preferred by sponsors, and which are being used by respondents. These data are split by Phase I, Phase II/III and Phase IIIb/IV services.

2. Market Dynamics: This section details sponsors’ reports of outsourcing levels – by phase – for the past 12 months and for the next 12 months.

3. Service Provider Selection: This section calls out the important criteria by which sponsor companies select their providers and identifies which CRO attributes are increasing in importance.

4. Service Provider Differentiation: provides CROs with sponsor perspectives on various differentiating attributes.

5. Service Provider Performance: The lion’s share of the report shines a light on service providers’ delivery quality. Specifically, it showcases providers’ attribute-by-attribute customer quality ratings, service variability and customer loyalty profiles. In addition, this section provides sponsors guidelines for the informed selection of their CROs using certain purchase scenarios.

As always, an appendix of Charts and Graphs is also included within this report with responses to all questions asked in this study.

What Readers Will Learn:

Readers will gain an in-depth understanding of:

• Delivery quality for 25 prominent CROs across 20 dimensions of service 
• Which CROs deliver consistent service and which are highly variable 
• Customer satisfaction and loyalty profiles for each service provider 
• What drives sponsors' selection of CROs for Phase I-IV studies 
• Sponsors' predictions for outsourcing volume, by phase, in the coming 12 months

Sponsors can rely on this report to substantially inform their selection of development partners that best fit their unique needs

Service providers can rely on this report to provide them with clear service enhancement recommendations and opportunities to differentiate themselves from the crowded, competitive market of CROs.

Similar Reports:

Purchasers of this report also purchased:

• 2011 CRO Quality Benchmarking
• Late Phase Market Dynamics
• The Future of Clinical Monitoring
• Clinical Development Staff & Resourcing Models